Experimental Cancer Drug Navitoclax Shows Promise in Enhancing Tuberculosis Treatment and Reducing Lung Damage According to Johns Hopkins Researchers
A pioneering study led by investigators at Johns Hopkins Medicine suggests that an experimental drug...
